KPDA gives notice of high-intensity responses to unfair pharmaceutical agreements

The Korea Pharmaceutical Distribution Association(KPDA) has given a notice of high-intensity responses to unfair agreements on a basis of its member companies’ reports.

The KPDA has pointed out agreements between pharmaceutical and distribution companies have frequently made with unfair terms and conditions.

Although the association planned to prepare for a standard contract after agreeing wi...